Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000891293-04-000014
Filing Date
2004-01-07
Accepted
2004-01-07 20:12:17
Documents
1
Period of Report
2004-01-05

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 5329
  Complete submission text file 0000891293-04-000014.txt   6933
Mailing Address
Business Address 201 ELLIOTT AVE W STE 400 SEATTLE WA 98119 2062707100
CELL THERAPEUTICS INC (Issuer) CIK: 0000891293 (see all company filings)

EIN.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address VIA ARIOSTO 23 BRESSO ITALY L6 0000
Business Address
SPINELLI SILVANO (Reporting) CIK: 0001274546 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-12465 | Film No.: 04514224